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Abstract Knowing the inter-unit variability, especially
the technological error, is important when using many
physiological measurement systems, yet no such inter-unit
analysis has been undertaken on duplicate automated gas
analysis systems. This study investigated the inter-unit
performance of two identical ParvoMedics TrueOne 2400
automated gas analysis systems during a range of sub-
maximal steady-state exercises performed on an electro-
magnetic cycle ergometer. Fifteen adult males were tested
on two separate days a rest, 30, 60, 90, and 120 Watts with
the duplicate gas analysis units arranged (1) collaterally
(2 min of steady-state expired gas was alternately passed
through each system), and (2) simultaneously (identical
steady-state expired gas was passed simultaneously through
both systems). Total within-subject variation (biologi-
cal ? technological) was determined from the collateral
tests, but the unique inter-unit variability (technological
error between identical systems) was shown by the simul-
taneous tests. Absolute percentage errors (APE), coefficient
of variations (CV), effect sizes and Bland–Altman analyses
were undertaken on the metabolic data, including expired
ventilation (VE), oxygen consumption (VO2) and carbon
dioxide production (VCO2). The few statistically significant
differences detected between the two duplicate systems
were determined to have small or trivial effect sizes, and
their magnitudes to be of little physiological importance.
The total within-subject variations for VO2, VCO2 and VE
each equated to a mean CV and mean APE value of*4 and
*6 %, whilst the respective inter-unit technological errors
equated to *1.5 and *2.1 %. The two ParvoMedics
TrueOne 2400 systems demonstrated excellent inter-unit
agreement.
Keywords Variation  Agreement  Technological error 
ParvoMedics  Gas analysis
Abbreviations
APE Absolute percentage error
CO2 Carbon dioxide
CV Coefficient of variation
FECO2 Fraction of expired carbon dioxide
FEO2 Fraction of expired oxygen
L min-1 Litres per minute
LOA Limits of agreement
N2 Nitrogen
O2 Oxygen
RER Respiratory exchange ratio
VO2 Oxygen consumption
VO2max Maximal oxygen consumption
VCO2 Carbon dioxide production
VE Expired ventilation
VEmax Maximal expired ventilation
W Watts
Introduction
The research community often benefits by being able to
compare physiological data across studies providing that
non-identical devices produce the same outputs when tes-
ted under the same conditions (good inter-system agree-
ment); for example, when several automated gas analysis
systems from different manufacturers provide comparable
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metabolic data on the same subjects (Cooper et al. 2009).
Yet the opposite is quite common, with non-identical gas
analysis systems producing less than acceptable agreement
(Miles et al. 1994).
When multiple identical devices are used to collect and
compare data from several measurement localities (e.g., each
site having the same model gas analysis system), it is essential
to test that each unit of the systems is not significantly biased
and indeed produces comparable results (i.e., low inter-unit
variability). Assessing inter-unit variability is quite different
from how the more common inter-system accuracy (validity)
is traditionally measured. Inter-unit variability is a measure of
how reproducible the results are when two or more identical
models of the measurement device are tested under the exact
same situations, including conditions that mimic the future
research methodology, and all units are tested at the same time.
In comparison, inter-system accuracy (validity), especially for
gas analysis systems, typically compares only one model of an
instrument against a quite different criterion/gold device,
typically a Douglas Bag system (Douglas 1911). Ideally both
metabolic measurements should occur ‘‘simultaneously’’
during the same steady-state activity (e.g., (Crouter et al.
2006), although they are often taken at different times during
steady-state activity due to interference between the mea-
surement systems (i.e., ‘‘collaterally’’ e.g., Vogler et al. 2010).
The total within-subject variance, as measured between
two gas analysis systems on the same subject(s) over two
different time periods, is the sum of the within-subject bio-
logical (temporal) variation ? technological error variation.
When comparison between two, or more, identical systems
occurs over exactly the same time periods and same condi-
tions (inter-unit agreement), the biological error component
is removed, allowing the true technological error between the
duplicate units to be measured. Knowing the technological
variability between duplicate units is important when col-
lating data across multi-centre trials each with a single unit,
or within-laboratory trials using multiple units.
A number of studies have examined the variance in
metabolic gas analysis systems. Using a Krogh-type gas-
ometer, Taylor (1944) reported the CV of the total variance
for submaximal VO2 (6.5 %) and VE (8.0 %), plus maxi-
mal values: VO2max (7.5 %) and VEmax (7.2 %), and
estimated VO2 ‘‘method error’’ (technological error) to be
*0.1–0.3 %. Using Douglas bags, Taylor et al. (1955)
reported the total variability in repeated VO2max tests to be
2.4 %, lower than the 5.5 % reported by Mitchell et al.
(1958), but much higher than the 0.26 % of McArdle et al.
(1973). Whilst the novel intra- and inter-lab reliability data
of Jones and Kane (1979) showed total percent variations in
VO2, VCO2, and VE of 3.8, 4.2 and 8.0 %, respectively, for
their short-term intra-lab tests. Using 80 repeated VO2max
trials with Douglas bags, Katch et al. (1982) reported the
total within-subject variation to be 5.6 %, with biological
error accounting for *90 % of this: the technological error
was therefore *10, or\0.4 % of the total VO2max variance
and almost identical to the findings from Armstrong and
Costill’s (1985) Rayfield system. In both these studies, the
low technological error reflected intra-unit reliability and is
likely to be lower than the unknown inter-unit variability.
More recently James and Doust (1997) reported a Douglas
bag technological error CV of 1.4 % using a same subject/
same(within)-bout protocol, but a higher CV of 2.1 % for
repeated VO2 measurement on the same subject, but on a
different exercise bout (biological and technological error).
Yet no study has yet reported an inter-unit variability
study on any automated gas analysis system and it is
unknown how much technological error occurs due purely to
calibration and/or hardware differences between two or
more identical units of the same system. Although two
studies have reported data collected from multiple models of
the same automated gas analysis system using the same
subjects across each device. Yule et al. (1996) measured
eight subjects during two submaximal and one maximal test
at the same time of day at three separate laboratories, all
using similar Sensormedics 2900 metabolic carts. Their
results showed significant differences in both VO2max and
respiratory exchange ratio (RER) between labs, with the
mean VO2max varying by 4–14 % between the three labs.
The HERITAGE Family study used eight travelling subjects
to examine the reproducibility of physiological variables
during two submaximal and one maximal test across four
laboratories, also using similar Sensormedics 2900 meta-
bolic carts (Gagnon et al. 1996; Skinner et al. 1999; Wilmore
et al. 1998). The submaximal tests produced a coefficient of
variation (CV) for VO2, VCO2 and VE that ranged from 3.5 to
4.7 %, 3.8 to 5.8 % and 5.1 to 6.9 %, respectively; whilst the
maximal test produced respective CV values of 4.1, 5.5 and
8.5 %. Although both studies reported insightful data on the
reproducibility between labs using the same measurement
systems, neither study was specifically designed to reveal
the true technological error between identical units. This
type of inter-unit variability study would have required both
studies to use absolute duplicates of the same metabolic
analysis systems (identical age, identical maintenance,
identical volume and gas calibrations, and identical testing
conditions). The variations reported in these two studies
between the Sensormedics 2900 machines will therefore
have been inflated by an unknown mixture of these tech-
nological sources of contamination; moreover, the results
are likely to have contained a measureable biological vari-
ation as the subjects were tested on different days. Another
study has reported metabolic data from two early Parvo-
Medics TrueMax systems configured to measure simulta-
neously gas exchange using the same eight subjects (Bassett
et al. 2001). However, these two systems were also not
identical, as the study aimed to compare the validity of the
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inspiratory system against the expiratory system, thus the
technological error between two identical gas analysis sys-
tems remains unknown.
A recent review on the performance of gas analysis
systems (Atkinson et al. 2005) has also stressed the
importance of detailing the sources of variation in gas
analysis systems. The aim of this study was therefore to
examine the variability of two identical ParvoMedics
TrueOne 2400 automated gas analysis units during a range
of submaximal bouts of exercise, by measuring: (1) the
combined biological and technological errors, where the
steady-state expired gases were alternately directed into
each system (set-up for ‘‘collateral’’ measurement of non-
identical gases/times: see Fig. 1a); and (2) technological
error only, where the expired gases flowed continuously
through both systems (set-up for ‘‘simultaneous’’ mea-
surement of identical gases/times: see Fig. 1b).
Methods
Participants
A sample of fifteen apparently healthy Hong Kong Chinese
male volunteers were recruited with the following
characteristics (mean ± SD): age 21.7 ± 1.4 year; height
175.1 ± 6.6 cm; mass 74.0 ± 11.4 kg. All subjects pro-
vided written informed consent, after the project was
approved by the Research Ethics Committee of the Uni-
versity of Hong Kong.
Equipment
ParvoMedics TrueOne 2400 systems. Both TrueOne 2400
units (see http://www.parvo.com) were identical models of
an automated ‘‘mixing chamber’’ metabolic gas analysis
system, comprising a measurement module connected to a
Dell Optiplex 790 computer running Windows 7 and Par-
oMedics OUSW 4.3.4 (v.20111228) data acquisition/anal-
ysis software. The two 2400 units were of identical age,
with the measurement modules having sequential manu-
facturing serial numbers (3845HU-NL, 3846HU-NL); each
unit had been installed by a ParvoMedics’ factory staff
within the previous 3 months and had been used *10
times each. Expired gas passed sequentially through a Hans
Rudolph (Shawnee, KS) 2700 two-way non-rebreathing
valve, a saliva collector trap, a Creative Biomedics Inc
(San Clemente, CA, USA) CB-1501-2 filter, a Hans
Rudolph series-3813 heated pneumotachometer, and into a
4 L mixing chamber. The mixed expired gas was then
Fig. 1 Illustration of the two experimental set-ups. a Collateral
configuration with alternating measurements of the same steady-state
activity made by the two identical gas analysis units. b Simultaneous
configuration with simultaneous measurements of the same steady-
state activity made by both identical gas analysis units, but sharing a
common mixing chamber
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continuously sampled using a 61 cm Nafion tube (Perma-
pure, Toms River, NJ, USA) by a paramagnetic oxygen
analyzer (0–25 % range with 0.1 % accuracy) and an
infrared carbon dioxide analyzer (0–10 % range, with
0.1 % accuracy) to measure fractions of expired oxygen
(FEO2) and carbon dioxide (FECO2). Both systems were
turned-on at least 30 min prior to testing and calibrated
according to the manufacturer’s instructions. This involved
the pneumotachometer being calibrated using five strokes
of a 3L syringe (Hans Rudolph series-5530) at graduated
flow-rates from 50 to 80 L min-1 up to [400 L min-1.
The gas analyzers were calibrated using a two-point fully
automated process involving room air and a certified gas
(3.98 % CO2, 16.03 % O2, balance N2: Airgas Specialist
Gases, Lenexa, KS). The certified calibration gas cylinders
for each system came from the same production run (Lot
ZP12Y161BB) and used identical Victor CGA973 pressure
regulators (Denton, TX). A minimum of two flowmeter and
two gas analyzer calibrations were performed before each
test. The ambient temperature, barometric pressure and
relative humidity were entered into each computer from
each system’s corresponding weather station (model WS-
2080; Ambient Weather, Chandler, AZ, USA); each
weather station had been corrected and matched with the
ParvoMedics’ factory standards.
Each participant sat on a Lode (Groningen, The Neth-
erlands) Corival 400 electromagnetically braked cycle
ergometer, wore a noseclip, and breathed through a
mouthpiece attached to a Hans Rudolph 2700-series non-
rebreathing valve that was held by a Hans Rudolph 2726
head-support. Each participant also wore a telemetric heart
rate monitor (Polar, Kempele, Finland). The experimental
set-up differed slightly between the two tests.
Collateral set-up (Fig. 1a)
Expired gas from the 2700 valve passed through a 13-cm
corrugated plastic tube (35 mm diameter) to a Hans
Rudolph 2100-series 3-way stopcock, so the experimenter
could alternately direct it into one of the two TrueOne 2400
units via a 180-cm corrugated plastic tube (35 mm diame-
ter). The flowmeters for each system were calibrated man-
ually within *1 min of each other, whilst the automated
gas calibrations were done simultaneously before each test.
Each participant underwent a continuous incremental sub-
maximal exercise test using five steady-state periods (Rest,
30, 60, 90, 120 W at constant pedal frequency of 60 rpm),
each lasting 7 min. A steady-state was achieved over the
first 3 min, then 2 min of steady-state expired gas was
directed into one 2400 unit (3rd–5th minute), then switched
to the alternate 2400 unit for the 5th–7th minute; after the
7th minute, the work rate was increased and the sequence
was repeated. During the initial 3 min of each exercise
stage, the 2100 stopcock was used to periodically alternate
gas into each system to ensure each mixing chamber had
similar mixed expired gas compositions. To prevent an
order effect, the sequence of the 2400 units was balanced by
switching them after each participant.
Simultaneous set-up (Fig. 1b)
Expired gas from the 2700 valve passed directly into both
the TrueOne 2400 units via a 180-cm corrugated plastic
tube (35 mm diameter), with the two pneumotachometers
separated by a 13-cm corrugated plastic tube (35 mm
diameter). To prevent an order effect, the positioning of the
pneumotachometers was balanced by switching them after
each participant. Manual calibration of both pneumota-
chometers was then able to be performed simultaneously
before each test, along with simultaneous automated cali-
brations of both sets of gas analyzers. After a period of at
least 1 week from the collateral test, each participant
underwent a second continuous incremental submaximal
exercise test using the same five steady-state bouts (Rest 30,
60, 90, 120 W), but each lasting only 5 min (the previous
5th–7th minute period was not required, as steady-state gas
passed simultaneously through both units over the 3rd–5th
minute), before the work rate was increased. To ensure
exact ventilatory synchrony between the two metabolic
systems, participants were asked to momentarily hold their
breath (i.e., zero gas flow), whilst data acquisition for both
units was simultaneously started, thereby ensuring each unit
recorded an identical number and sequence of breaths.
Data processing/analysis
Both units reported a 30 s average in all metabolic data. At
the end of each test, the data file was exported and analyzed
using MicroSoft Excel 2011, with the mean of the final 90 s
of each 2 min period of steady-state used in the final analysis.
We selected a variety of reliability statistics for each vari-
able, as has been recommended (Atkinson and Nevill 1998;
Hodges et al. 2005). These included: the absolute percentage
error (APE) and individual coefficient of variation expressed
as a percentage of the mean score (CV) (McClain et al.
2007); the effect size (ES) being the magnitude of the group
difference relative to the overall standard deviation (Cohen
1988); Bland–Altman plots (Bland and Altman 1986); and
shifts in mean scores using paired t tests with Holm’s
sequential Bonferroni adjustments (Holm 1979).
Results
Table 1 shows that the metabolic data from the two auto-
mated gas analysis units arranged collaterally were very
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similar across all workloads, with no statistically signifi-
cant differences in any of the mean comparisons (after
Holm–Bonferroni adjustment). Except for the Rest condi-
tion (when the relative error was expected to be higher), the
APE and CV values tended to range between 2 and 4 %.
All effect sizes were below 0.32, with 21 of the 30 (70 %)
classified (Saunders 2004) as being trivial (\0.2) and the
remaining 30 % as small (0.2–0.5). The Bland–Altman
plots in Fig. 2a, c, e, show very minor systematic error
(bias) between the two collateral systems, with almost no
proportional random error, and small 95 % limits of
agreement (LOA).
The metabolic data in Table 2 from the two gas analysis
units arranged simultaneously show that the inter-unit
agreement was higher compared to the collateral test, as
predicted. Even though the p values from the paired t tests for
FEO2 and RER were often very small (and traditionally
regarded as being significant, p \ 0.05), this reflected the
extremely consistent intra-unit variation (very low standard
deviations or ‘noise’) rather than a relatively large bias in the
Table 1 Physiological responses from the graded exercise test using two ‘‘collateral’’ systems (1 and 2: mean ± SD), and p value from paired
t tests, absolute percentage error (APE), coefficient of variation (CV), and effect size
Variable System 1 System 2 Paired t p value APE mean (range) CV mean (range) Effect size
VE (L min
-1)
Rest 11.91 ± 6.29 11.84 ± 6.14 0.850 12.4 (2.0–39.7) 8.4 (1.4–23.4) 0.01
30 W 19.57 ± 4.29 20.01 ± 4.47 0.110 4.3 (0.5–12.9) 2.9 (0.4–8.6) 0.11
60 W 26.83 ± 3.40 27.41 ± 3.50 0.280 6.7 (0.0–18.1) 4.6 (0.0–11.7) 0.17
90 W 37.37 ± 4.49 37.94 ± 3.43 0.160 3.1 (0.1–11.7) 2.2 (0.1–7.8) 0.15
120 W 49.33 ± 7.49 50.71 ± 5.64 0.170 6.2 (0.4–17.3) 4.2 (0.3–11.2) 0.21
VO2 (L min
-1)
Rest 0.30 ± 0.06 0.31 ± 0.06 0.780 11.6 (1.1–26.2) 8.1 (0.8–20.2) 0.05
30 W 0.73 ± 0.08 0.74 ± 0.08 0.200 4.7 (0.0–16.5) 3.2 (0.0–10.8) 0.18
60 W 1.06 ± 0.08 1.07 ± 0.08 0.380 4.2 (0.7–9.4) 2.9 (0.5–7.0) 0.17
90 W 1.44 ± 0.09 1.46 ± 0.07 0.340 3.1 (0.1–10.5) 2.2 (0.1–7.1) 0.20
120 W 1.83 ± 0.14 1.85 ± 0.10 0.320 3.7 (0.2–8.5) 2.6 (0.1–5.7) 0.18
VCO2 (L min
-1)
Rest 0.28 ± 0.09 0.28 ± 0.10 0.720 12.6 (1.0–37.4) 8.6 (0.7–22.3) 0.04
30 W 0.63 ± 0.08 0.64 ± 0.09 0.160 4.5 (0.5–14.9) 3.1 (0.4–9.8) 0.17
60 W 0.95 ± 0.08 0.97 ± 0.08 0.120 5.2 (0.1–13.5) 3.5 (0.1–9.0) 0.32
90 W 1.36 ± 0.11 1.39 ± 0.09 0.090 3.3 (0.2–14.0) 2.2 (0.2–9.2) 0.27
120 W 1.77 ± 0.19 1.82 ± 0.17 0.070 3.9 (0.1–13.4) 2.7 (0.1–8.9) 0.26
FEO2 (%)
Rest 17.58 ± 0.60 17.57 ± 0.55 0.890 1.1 (0.2–2.9) 0.8 (0.1–2.0) 0.02
30 W 16.42 ± 0.54 16.43 ± 0.58 0.810 0.6 (0.1–1.9) 0.4 (0.1–1.3) 0.02
60 W 16.14 ± 0.45 16.18 ± 0.43 0.500 0.9 (0.0–2.8) 0.6 (0.0–2.0) 0.08
90 W 16.21 ± 0.37 16.24 ± 0.31 0.600 0.8 (0.0–2.5) 0.6 (0.0–1.7) 0.08
120 W 16.37 ± 0.37 16.44 ± 0.36 0.170 1.1 (0.2–2.1) 0.8 (0.1–1.5) 0.20
FECO2 (%)
Rest 3.06 ± 0.40 3.06 ± 0.37 0.840 3.7 (0.1–12.6) 2.6 (0.0–8.4) 0.02
30 W 4.03 ± 0.46 4.02 ± 0.47 0.860 2.2 (0.4–7.6) 1.6 (0.3–5.6) 0.01
60 W 4.41 ± 0.42 4.42 ± 0.43 0.560 2.1 (0.1–5.4) 1.5 (0.1–3.7) 0.05
90 W 4.55 ± 0.38 4.55 ± 0.33 0.890 2.6 (0.6–7.9) 1.8 (0.4–5.4) 0.01
120 W 4.48 ± 0.32 4.46 ± 0.34 0.610 3.1 (0.4–6.6) 2.2 (0.3–4.5) 0.07
RER
Rest 0.90 ± 0.13 0.90 ± 0.15 0.930 4.1 (0.0–14.3) 2.9 (0.0–10.9) 0.01
30 W 0.86 ± 0.04 0.86 ± 0.06 0.770 2.6 (0.1–7.5) 1.8 (0.0–5.1) 0.05
60 W 0.89 ± 0.04 0.90 ± 0.04 0.090 2.5 (0.2–7.6) 1.7 (0.1–5.2) 0.29
90 W 0.95 ± 0.03 0.95 ± 0.05 0.210 2.0 (0.0–7.3) 1.4 (0.0–5.0) 0.22
120 W 0.97 ± 0.04 0.98 ± 0.05 0.070 2.6 (0.3–4.9) 1.8 (0.2–3.4) 0.30
* Significantly different means by paired t test with Holm’s sequential Bonferroni adjustment
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inter-unit signal. As a result, even a very small (and physi-
ologically trivial) systematic error/bias between the two units
would appear to be large relative to the small standard
deviation. Yet only one pairing produced a statistically sig-
nificant difference between mean values (RER at 120 W)
after Holm–Bonferonni adjustment; but the small APE and
CV for this pair of 0.8 and 0.6 %, respectively, and a trivial
effect size (0.16) all confirmed this was a physiologically
insignificant difference. Overall, most APE and CV values
for the simultaneous comparison were very small, typically
varying around 0.5–2.0 %, with all effect sizes being trivial
(maximum of 0.16); indeed, 77 % of the effect sizes were
\0.1. This extremely good inter-unit agreement was further
confirmed by the Bland–Altman plots B, D, and F in Fig. 2,
that show almost no systematic error, together with uniform
random error, and very small 95 % LOA.
Discussion
This is the first study to examine the inter-unit variability of






Fig. 2 Bland–Altman plots from the collateral (a, c, e) and simul-
taneous (b, d, f) tests, showing the error scores for the two gas
analysis systems (Test unit 1 - Test unit 2); data shown for VE (a, b),
VO2 (c, d), and VCO2 (e, f). Solid horizontal line indicates the mean
error, whilst the dashed horizontal lines indicate the 95 % LOA
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analysis systems. Analysis of the simultaneous set-up
permits the first in situ assessment of the technological
error that occurs between two identical automated gas
analysis units due to the small variations that cannot be
fully eliminated in the calibration process and/or due to
variations associated with the data-acquisition/processing
hardware (e.g., different inter-unit manufacturing toler-
ances and inherent intra-unit measurement noise). This
study also provided data on the added variation created
when a small level of biological error was introduced. This
added biological error was due to the non-simultaneous
sampling of inherently imperfect steady-state measure-
ments of human respiration (the collateral test), as opposed
to using ideal steady-state conditions generated by
mechanical metabolic calibration systems (Gore et al.
1997; Vogler et al. 2010).
A review of the variability measured between repeated
submaximal or maximal tests using recent automated gas
analysis systems is beyond the scope of this paper and
aspects have been reported elsewhere (Crouter et al. 2006;
Table 2 Physiological responses from the graded exercise test using two ‘‘simultaneous’’ systems (1 and 2: mean ± SD), and p value from
paired t tests, absolute percentage error (APE), coefficient of variation (CV), and effect size
Variable System 1 System 2 Paired t p value APE mean (range) CV mean (range) Effect size
VE (L min
-1)
Rest 12.26 ± 3.26 12.21 ± 3.30 0.555 2.6 (0.1–9.2) 1.8 (0.0–6.2) 0.02
30 W 19.70 ± 2.49 19.63 ± 1.94 0.752 2.6 (0.1–10.8) 1.9 (0.1–7.3) 0.03
60 W 27.16 ± 2.75 27.15 ± 2.38 0.991 2.1 (0.2–6.4) 1.5 (0.2–4.4) 0.00
90 W 37.13 ± 5.08 37.19 ± 4.93 0.750 1.7 (0.1–4.1) 1.2 (0.1–2.8) 0.01
120 W 47.86 ± 6.09 48.27 ± 5.73 0.173 1.8 (0.1–6.1) 1.2 (0.1–4.2) 0.07
VO2 (L min
-1)
Rest 0.32 ± 0.05 0.31 ± 0.04 0.102 2.9 (0.9–7.0) 2.0 (0.6–4.8) 0.10
30 W 0.73 ± 0.08 0.73 ± 0.07 0.420 2.6 (0.1–9.2) 1.8 (0.1–6.8) 0.09
60 W 1.05 ± 0.09 1.04 ± 0.08 0.423 1.9 (0.1–7.2) 1.4 (0.1–5.3) 0.08
90 W 1.42 ± 0.08 1.41 ± 0.07 0.327 1.6 (0.1–5.2) 1.1 (0.1–3.8) 0.10
120 W 1.78 ± 0.13 1.78 ± 0.12 0.823 1.6 (0.1–4.5) 1.1 (0.0–3.3) 0.02
VCO2 (L min
-1)
Rest 0.29 ± 0.06 0.29 ± 0.06 0.702 2.4 (0.3–9.2) 1.7 (0.2–6.2) 0.02
30 W 0.64 ± 0.07 0.64 ± 0.06 0.885 2.6 (0.3–10.7) 1.8 (0.2–7.2) 0.01
60 W 0.95 ± 0.07 0.95 ± 0.07 0.856 2.1 (0.2–6.1) 1.5 (0.1–4.5) 0.02
90 W 1.37 ± 0.11 1.37 ± 0.12 0.698 1.7 (0.0–3.9) 1.2 (0.0–2.7) 0.03
120 W 1.75 ± 0.16 1.77 ± 0.15 0.163 1.7 (0.0–5.9) 1.2 (0.0–4.0) 0.10
FEO2 (%)
Rest 17.73 ± 0.57 17.75 ± 0.57 0.008 0.1 (0.0–0.4) 0.1 (0.0–0.3) 0.03
30 W 16.46 ± 0.41 16.48 ± 0.41 0.007 0.2 (0.0–0.6) 0.1 (0.0–0.4) 0.06
60 W 16.27 ± 0.35 16.29 ± 0.34 0.012 0.2 (0.0–0.6) 0.1 (0.0–0.4) 0.07
90 W 16.22 ± 0.45 16.25 ± 0.44 0.006 0.2 (0.0–0.6) 0.1 (0.0–0.4) 0.06
120 W 16.34 ± 0.42 16.37 ± 0.41 0.003 0.2 (0.0–0.6) 0.1 (0.0–0.4) 0.07
FECO2 (%)
Rest 2.99 ± 0.39 3.00 ± 0.39 0.081 0.3 (0.0–1) 0.2 (0.0–0.7) 0.01
30 W 4.05 ± 0.37 4.05 ± 0.37 0.497 0.2 (0.0–0.8) 0.2 (0.0–0.6) 0.01
60 W 4.37 ± 0.37 4.37 ± 0.37 0.491 0.3 (0.0–1.0) 0.2 (0.0–0.7) 0.01
90 W 4.60 ± 0.37 4.60 ± 0.37 0.863 0.3 (0.0–0.7) 0.2 (0.0–0.5) \0.01
120 W 4.56 ± 0.36 4.56 ± 0.36 0.792 0.3 (0.0–0.8) 0.2 (0.0–0.5) \0.01
RER
Rest 0.92 ± 0.12 0.93 ± 0.13 0.010 1.1 (0.1–4.1) 0.8 (0.1–2.8) 0.09
30 W 0.87 ± 0.05 0.88 ± 0.05 0.002 0.8 (0.2–2.1) 0.6 (0.1–1.5) 0.14
60 W 0.91 ± 0.04 0.92 ± 0.04 0.002 0.8 (0.1–2.0) 0.6 (0.1–1.4) 0.15
90 W 0.96 ± 0.06 0.97 ± 0.06 0.003 0.9 (0.2–1.9) 0.6 (0.1–1.3) 0.12
120 W 0.98 ± 0.04 0.99 ± 0.05 0.002* 0.8 (0.0–1.8) 0.6 (0.0–1.3) 0.16
* Significantly different means by paired t test with Holm’s sequential Bonferroni adjustment
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Hodges et al. 2005; Macfarlane 2001). However, some
relevant comparative data indicate the total variations in
reliability measures of VO2, VCO2, and VE over 2 days
using the ParvoMedics 2400 system produced a respective
CV of 4.7, 5.7 and 7.3 % (Crouter et al. 2006). In com-
parison, the respective CV values from the collateral tests
in this current study of 3.8, 4.0, and 4.5 % are all pre-
dictably lower since the variability measured during two
sections of the same steady-state on the same day (collat-
eral test), will be lower than that seen during two separate
steady-states measured across two different days (Crouter-
study). The current study’s collateral testing should there-
fore represent some of the smallest possible within-subject
variation (biological ? technological).
If the technological variability (simultaneous tests) is
subtracted from the total within-subject variability (col-
lateral tests), the biological variability remains. When this
is done for the mean VO2, VCO2, and VE data, then the
respective biological variation APE values are 3.3, 3.8, and
4.4 %, whilst the CV values are 2.3 , 2.5, and 2.9 %. The
mean CV for the VO2 biological variation in our study of
2.3 % is predictably lower than the 5.2 % reported by
Katch et al. (1982), since our study used a same day within-
exercise comparison, rather than a between-day compari-
son used by Katch et al. The biological APE of 2.3 % in
our VO2 data from our highest steady-state exercise is very
similar to the 2 % estimated by Withers et al. (2000) for
VO2max data taken across 5 certified Australian laborato-
ries. However, our novel findings show that even when
taking measurements by two identical metabolic systems
during the same theoretical ‘‘steady-state exercise’’, some
small biological variation is measurable above the
between-system technological variation. This measurable
biological variation may have been due to a slight upward
drift in the metabolic rate due to the relatively slow kinetic
change in core body temperature, as heart rate also showed
a small mean APE difference of 3.3 % during the collateral
tests (compared to a trivial 0.3 % for the simultaneous
tests).
The data in Table 2 indicate that the technological error
due to differences in calibration and/or instrumentation
noise is consistently less than an APE of 3 % and below a
CV of 2 %, with variations in measured VO2 and VCO2
predominantly being due to variations in VE rather than
FEO2 or FECO2. The level of agreement between the iden-
tical sets of O2 and CO2 analyzers when measuring
‘‘identical’’ mixed expired gas (simultaneous) was
impressively low at 0.1–0.3 % for both APE and CV,
indicating that the auto-gas calibration routine and per-
formance of the ParvoMedics gas analyzers were extre-
mely precise. The mean technological variation between
our two identical ParvoMedics systems when measuring
VO2 (APE = 2.1 %; CV = 1.5 %) was also predictably
higher than the values reported by four other studies
(Armstrong and Costill 1985; James and Doust 1997;
Katch et al. 1982; Taylor 1944), as our study compared
inter-unit variability (differences between two identical
systems), rather than the intra-unit variability (repeatability
of a single system), which was reported in the above four
studies. Despite this, our technological CV of 1.5 %
remains considerably lower that than ‘‘much of the CV of
5 %’’ also attributed to technological error from the 2-day
test–retest data described by Shephard et al. (2004).
Our technological error was slightly elevated since each
of the two 2400 systems used its own ambient weather
station for temperature, pressure and relative humidity (see
‘‘Methods’’), rather than one common laboratory standard.
Although these weather stations were re-calibrated to a
ParvoMedics factory standard, very small variations (mean
APE) were seen in temperature (1.3 %), pressure (\0.1 %),
and relative humidity (2.8 %) between the two systems,
which would have influenced the technological error in the
calculation of VO2, VCO2 and VE. However, the cumulative
effect of these inter-unit variations in ambient variables
would cause less then a 0.2 % error in the calculation of the
important VO2 variable (Howley et al. 1995; Withers et al.
2000), and is of little physiological importance. Two other
factors may have contributed in a minor way to the
‘‘simultaneous condition’’ technological error: (a) the small
13 cm tubing that connected the two pneumotachometers
may have added a small downstream deadspace, and
(b) heating of the expirate by the proximal pneumota-
chometer may have caused a small volume increase that
was measured by the distal pneumotachometer. However,
we surmise that switching the order of the pneumota-
chometers after each test should have minimized their net
effect.
There remains no universally accepted level of precision
(nor accuracy) for the measurement of the important met-
abolic variable of VO2 (Macfarlane 2001), and although a
technical error of measurement (TEM) target of 3 % for
VO2max has been recommended by Gore (2000), the coef-
ficient of variation appears to be the more commonly used
statistic to report data from reliability/precision test–ret-
ests. During high intensity VO2 tests, a CV of *4–5 %
(total within-subject variability in VO2) is frequently
reported in the literature from intra-unit reliability analyses
from separate bouts at the same work rate (Armstrong and
Costill 1985; Becque et al. 1993; Bingisser et al. 1997;
Carter and Jeukendrup 2002; Clark et al. 2008; Crouter
et al. 2006; Froelicher et al. 1974; Howley et al. 1995;
James and Doust 1997; Jones 1984; Nordrehaug et al.
1991; Rosdahl et al. 2009; Skinner et al. 1999). Although
we did not attempt VO2max measures during our inter-unit
comparison of the ParvoMedics systems, the CV for VO2
from our highest steady-state work rate was 2.6 %
760 Eur J Appl Physiol (2013) 113:753–762
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(APE = 3.7 %), which compares very favorably with the
often cited 4–5 % range. These results suggest that under
very well controlled test–retest situations (i.e., our collat-
eral tests, that involved minimal biological error due to
measurements taken within the same steady-state bout, plus
minimal technological error due to duplicate ParvoMedics
systems), the total variation between two automated gas
analysis systems can provide a CV \3 % at high work
rates. Furthermore, our APE of 3.7 % also suggests that the
targeted 4–5 % limit between two metabolic systems
(Babineau et al. 1999) can be achieved, albeit, under very
tightly controlled circumstances.
No other study has examined the technological error
between two identical systems (our inter-unit simultaneous
test), hence comparative data are not available. However,
some comparison can be made with the extremely well
controlled intra-unit precision tests undertaken using a
highly specialized automated VO2 calibration system (Gore
et al. 1997). When measuring identical respiratory gases
from the automated calibrator, the three gas analysis sys-
tems measured by Gore’s team produced a mean CV\1 %
for VO2, VCO2, and VE. When compared to these excellent
intra-unit measures of precision, the mean CV for VO2,
VCO2, and VE was *1.5 % from our inter-unit comparison
(mean APE *2.1 %). The slightly higher CVs seen in our
in-series study remain impressive, since our data were from
an inter-unit comparison collected during ‘‘real-life’’ lab-
oratory conditions using actual human volunteers, rather
than the intra-unit comparisons using precisely simulated
mechanical respiration of Gore et al. (1997). Our mean
inter-unit APE of *2.1 % is also very similar to the ±2 %
recommendation for intra-unit reliability suggested by
Hodges et al. (2005), indicating that the low inter-unit
variability seen between our duplicate ParvoMedics sys-
tems can effectively match the tolerances traditionally
recommended for intra-unit variability.
This study has several limitations, including that only
two duplicate ParvoMedics systems were analyzed, but we
have no reason to expect the low variability seen between
our systems would not be indicative of other recent True-
One 2400 systems. Unlike some studies we also did not use
any form of automatic gas exchange calibration systems
(Gore et al. 1997; Macfarlane and Wong 2011) to test these
systems, as we wished to report their performance under
‘‘real-life’’ laboratory conditions, as has been recom-
mended (Atkinson et al. 2005).
Summary
When tested collaterally using a range of submaximal
steady-state cycle ergometer tests, the duplicate Parvo-
Medics TrueOne 2400 systems produced total within-
subject variations for VO2, VCO2 and VE that each equated
to *4 % CV and *6 % APE. The simultaneous tests
demonstrated that the inter-unit technological error equated
to *1.5 % CV and *2.1 % APE, thus the biological error
within the collateral tests amounted to *3.5 % CV and
*4 % APE. The few statistically significant differences
detected between the duplicate systems were considered to
have small or trivial effect sizes and their magnitudes to be
of little physiological importance. Overall, the two Parvo-
Medics systems demonstrated very high inter-unit agree-
ment and exceeded the performance criteria often expected
of gas analysis systems.
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